Will Kaback
speaker
1,313 appearances
13 recordings
1 series
first heard Aug 2026
last heard 5d ago
Will Kaback’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 13 in all, peaking in Sep 2026 with 12.
Appearances
In Vox, Dylan Scott suggested Americans still have a toxic relationship with weight.
GLP-1 drugs promised to usher in a new era of treating obesity as a disease.
We could leave behind the anti-fat biases of the past, which blamed obesity on moral failing or personal weakness.
Instead, these drugs would allow us to approach it as a medical condition, a complex matrix of genetics and other forces which could be changed with the right dose of these powerful new medicines.
Or so the thinking went.
Even as millions of Americans shed pounds in bulk for the first time, they're also contenting with fierce stigma and shaming from others.
Instead of being criticized for being fat, they're being criticized for using GLP-1s.
Americans have internalized the message that being overweight is a personal failure so thoroughly that now that the kind of extraordinarily powerful weight loss shots and pills long hoped for are here, many people struggle to see it as good news.
They see it as cheating.
In the New York Times, Jessica Groves suggested, GLP-1s feed our sick culture.
Multiple things can be true about GLP-1s.
They are truly miracles and may treat a whole range of conditions beyond obesity and diabetes.
And they are often misused, partly because we have told women in multiple ways that being thin makes them valuable.
As my colleague has written, our culture, quote, makes being fat a woman's burden, a means test for dignity, work, social status, and moral citizenry, end quote.
In a recent study, researchers found that the use and misuse of GLP-1s is higher among people with eating disorders than among the general population, and that some of them may be attempting to maintain their, quote, eating disorder psychopathology through rapid restriction and weight loss, end quote.
they found that over 10% of participants with anorexia had tried GLP-1s.
Though GLP-1s may be a promising treatment for some kinds of disordered eating, like binge eating disorder, it appears much riskier for women with other kinds of diagnoses.
That's what the right and left are saying about this topic.
Now over to Audrey for her take.
Now here's a note about the stories that we didn't cover this week.
Showing 81–100 of 1,313 · page 5 of 66
← Previous
Next →